TAG:
laboratory consolidation
Successful Specialty IPO Can Open Door for Others
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: It’s no secret that a handful of laboratory companies would like to complete an initial public offering (IPO). If Specialty Labs’ public offering goes well, expect these lab companies to bring their own stock offerings to the public equity markets. As the number of public…
Genesis Clinical Laboratory Hits Outreach Home Run
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
CEO SUMMARY: Commercial laboratory consolidation has left Chicago with only a handful of laboratory providers. New management at MacNeal Hospital’s for-profit laboratory division recognized this opportunity. During the past three years, the outreach program was revitalized and the sales…
War College Identifies Emerging Lab Trends
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Disruptive technologies and the arrival of healthcare E-commerce were two common themes which emerged from this year’s Executive War College on Laboratory and Pathology Management. Consensus by faculty and attendees alike was that every lab organization should have an Inter…
Hospital Labs To Regain Pre-Eminence in Coming Years
By Robert Michel | From the Volume VII No. 6 – April 17, 2000 Issue
CEO SUMMARY: During the past five years, powerful forces in the healthcare marketplace positioned hospital-based laboratories to once again become the dominant force in laboratory testing. But this can only occur if today’s generation of hospital laboratory directors and clinical pathol…
Independent California Lab Decides to Exit Business
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: Market forces in California continue to put independent laboratories under sustained financial stress. One laboratory owner decided it was an auspicious time to sell his lab. That sale, of POISONLAB to Laboratory Corporation of America, was announced earlier this month. There…
“State of Lab Industry” Holds Surprises for All
By Robert Michel | From the Volume VII No. 1 – January 3, 2000 Issue
CEO SUMMARY: Say goodbye to several of the trends which shaped the lab industry during the 1990s, such as consolidation and government compliance programs. Although these trends won’t completely disappear, they will be superseded by a number of new transformational influences. During th…
Internet-Based Lab Info Racing Into Marketplace
By Robert Michel | From the Volume VI No. 15 – November 1, 1999 Issue
CEO SUMMARY: It’s another roller coaster ride for clinical laboratories and pathology practices. Within 24 months, virtually all physician offices will be using web-based technology to order lab tests and receive test results. Web-based ordering/reporting of laboratory testing will driv…
Wedding Between AutoCyte and NeoPath Will Spawn A Single Prep/Screen System
By Robert Michel | From the Volume VI No. 10 – July 19, 1999 Issue
CEO SUMMARY: Various technologies that automate cytology and Pap smear screening entered the clinical marketplace during the last four years. Because managed healthcare views new technology with a more skeptical eye than fee-for-service healthcare, THE DARK REPORT has provided extensive a…
Quest and SBCL Expect Merger Date Of July 2
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
CEO SUMMARY: After months of waiting and planning, executives at Quest Diagnostics Incorporated believe that July 2, 1999 will be the date when their acquisition of SmithKline Beecham Clinical Laboratories becomes official. During the month of July, expect a flurry of activity at Quest Di…
Labs Entering New Cycle Of Evolution and Change
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
CEO SUMMARY: As some of the nation’s most astute and forward-looking lab executives prepare to gather in New Orleans for the fourth annual EXECUTIVE WAR COLLEGE, it is time to share our assessment of the laboratory and pathology industry. Recent events presage another profound …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized